Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4607]

ASCO 2023: Results of SWOG S1929 trial show small-cell lung cancer patients with SLFN11 expression can benefit from PARP inhibitor added to immune checkpoint blockade

ASCO 2023: Results of SWOG S1929 trial show small-cell lung cancer patients with SLFN11 expression can benefit...

ASCO 2023: Immunotherapy for brain cancer metastases shows clinical benefit

ASCO 2023: Immunotherapy for brain cancer metastases shows clinical benefit

ASCO 2023: Adding ribociclib to hormonal therapy reduces risk of recurrence for people with most common subtype of breast cancer

ASCO 2023: Adding ribociclib to hormonal therapy reduces risk of recurrence for people with most common subtype of...

ASCO 2023: Taxane-induced peripheral neuropathy in breast cancer: Frequent, clinically significant, and worse with paclitaxel

ASCO 2023: Taxane-induced peripheral neuropathy in breast cancer: Frequent, clinically significant, and worse with...

ASCO 2023: Thyroid cancer precision approaches that incorporate targeted therapies and other treatments are changing the surgeon’s role

ASCO 2023: Thyroid cancer precision approaches that incorporate targeted therapies and other treatments are...

Personalising prostate cancer screening may improve the accuracy of detection

Personalising prostate cancer screening may improve the accuracy of detection

New data informs treatment of blood cancer during pregnancy

New data informs treatment of blood cancer during pregnancy

First-of-its-kind open-analysis platform for paediatric brain tumours provides robust data resource for childhood cancer research

First-of-its-kind open-analysis platform for paediatric brain tumours provides robust data resource for childhood...

Initiative will test new drug combinations guided by tumour biology

Initiative will test new drug combinations guided by tumour biology

Researchers uncover potential novel therapeutic targets against natural killer/T-cell lymphoma

Researchers uncover potential novel therapeutic targets against natural killer/T-cell lymphoma

More from ecancer